Legislation enacted in 2013 provides for increased government oversight of sterile prescription compounding facilities in order to improve the quality and safety of these medications.
Download our latest guide which provides an overview of these legislative changes and examines their potential impact on ophthalmology practices and patients including:
- A visual timeline of legislative oversight
- The history of legislative oversight in the compounding industry
- Introduction of the Drug Quality and Security Act
- Putting best practices into action